Novonix Limited
NVNXF
$0.20
-$0.04-16.91%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.40M | 1.40M | 1.41M | 1.41M | 1.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.40M | 1.40M | 1.41M | 1.41M | 1.56M |
| Cost of Revenue | 928.50K | 928.50K | 321.70K | 321.70K | 382.50K |
| Gross Profit | 471.30K | 471.30K | 1.09M | 1.09M | 1.17M |
| SG&A Expenses | 10.40M | 10.40M | 12.15M | 12.15M | 10.86M |
| Depreciation & Amortization | 1.14M | 1.14M | 1.15M | 1.15M | 1.15M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.29M | 14.29M | 14.63M | 14.63M | 13.80M |
| Operating Income | -12.89M | -12.89M | -13.22M | -13.22M | -12.24M |
| Income Before Tax | -36.28M | -36.28M | -10.07M | -10.07M | -23.01M |
| Income Tax Expenses | 12.80K | 12.80K | -- | -- | 48.80K |
| Earnings from Continuing Operations | -36.29M | -36.29M | -10.07M | -10.07M | -23.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.29M | -36.29M | -10.07M | -10.07M | -23.06M |
| EBIT | -12.89M | -12.89M | -13.22M | -13.22M | -12.24M |
| EBITDA | -12.09M | -12.09M | -12.07M | -12.07M | -11.41M |
| EPS Basic | -0.05 | -0.05 | -0.02 | -0.02 | -0.05 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.05 | -0.05 | -0.02 | -0.02 | -0.05 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 735.31M | 735.31M | 628.04M | 628.04M | 504.84M |
| Average Diluted Shares Outstanding | 735.31M | 735.31M | 628.04M | 628.04M | 504.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |